Many Patient, Consumer Reps On FDA Advisory Panels Have Conflicts Of Interest, Analysis Finds

Many Patient, Consumer Reps On FDA Advisory Panels Have Conflicts Of Interest, Analysis Finds Patient or consumer representatives with active ties to advocacy groups funded by pharmaceutical companies were present at nearly 40% of all FDA advisory committee meetings, Stat reported. Although the FDA has well-established conflict-of-interest policies for its scientific advisory committee members, policies surrounding patient and consumer reps are not as developed, Stat wrote. https://kffhealthnews.org/morning-breakout/pharma-and-tech-101426/